Stock Events

Stock Events

NANOGROUP SPÓŁKA AKCYJNA 

zł2.27
8
-zł0.08-3.62% 14:30 Today

Statistics

Day High
2.35
Day Low
2.23
52W High
3.2
52W Low
2.18
Volume
577,855
Avg. Volume
-
Mkt Cap
96.55M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-9.45MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NNG.WA. It's not an investment recommendation.
XTB SPÓŁKA AKCYJNA
3
XTB.WA
CD PROJEKT RED SPÓŁKA AKCYJNA
2
CDR.WA
POWSZECHNY ZAKŁAD UBEZPIECZEŃ SPÓŁKA AKCYJNA
2
PZU.WA
MURAPOL SPÓŁKA AKCYJNA
2
MUR.WA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novavax
NVAX
Mkt Cap1.66B
Novavax is involved in the development and commercialization of vaccines, which competes with Nanogroup's focus on nanotechnology in medicine.
Moderna
MRNA
Mkt Cap88.52B
Moderna uses mRNA technology for vaccines, overlapping with Nanogroup’s nanotechnology applications in drug delivery and therapeutics.
Pfizer
PFE
Mkt Cap173.95B
Pfizer develops vaccines and advanced biopharmaceuticals, competing in the same innovative medical solutions sector as Nanogroup.
BioNTech
BNTX
Mkt Cap22.15B
BioNTech works on personalized immunotherapies, which is a direct competition to Nanogroup’s efforts in nanotechnology-based treatments.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson engages in the research and development of medical devices and pharmaceuticals, aligning with Nanogroup's healthcare technology innovations.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories offers medical devices and healthcare solutions, competing with Nanogroup in the broader medical technology market.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca focuses on the development of pharmaceutical products, potentially competing with Nanogroup’s nanotechnology applications in drug development.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline specializes in pharmaceuticals and vaccines, areas where Nanogroup’s nanotechnology could be applied.
Novo Nordisk
NVO
Mkt Cap176.43B
Novo Nordisk is a global healthcare company that could utilize nanotechnology in its diabetes and obesity care, competing with Nanogroup.
Sanofi
SNY
Mkt Cap106.24B
Sanofi operates in pharmaceuticals and vaccines, similar to Nanogroup’s focus areas, potentially using nanotechnology for innovative solutions.

About

NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantology. The company was founded in 2016 and is based in Warsaw, Poland.
Show More
CEO
Przemyslaw Daniel Mazurek
Employees
46
Country
Poland
ISIN
PLNNGRP00011

Listings

WA
PL
NNG.WA

0 Comments

Share your thoughts

FAQs

What is NANOGROUP SPÓŁKA AKCYJNA stock price today?▼
The current price of NNG.WA is zł2.27 PLN — it has decreased by -3.62% in the past 24 hours. Watch NANOGROUP SPÓŁKA AKCYJNA stock price performance more closely on the chart.
What is NANOGROUP SPÓŁKA AKCYJNA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Warsaw Stock Exchange exchange NANOGROUP SPÓŁKA AKCYJNA stocks are traded under the ticker NNG.WA.
Is NANOGROUP SPÓŁKA AKCYJNA stock price growing?▼
NNG.WA stock has fallen by -2.6% compared to the previous week, the month change is a -8.91% fall, over the last year NANOGROUP SPÓŁKA AKCYJNA has showed a -10.36% decrease.
What is NANOGROUP SPÓŁKA AKCYJNA market cap?▼
Today NANOGROUP SPÓŁKA AKCYJNA has the market capitalization of 96.55M
What is NANOGROUP SPÓŁKA AKCYJNA revenue for the last year?▼
NANOGROUP SPÓŁKA AKCYJNA revenue for the last year amounts to 0 PLN.
What is NANOGROUP SPÓŁKA AKCYJNA net income for the last year?▼
NNG.WA net income for the last year is -9.45M PLN.
How many employees does NANOGROUP SPÓŁKA AKCYJNA have?▼
As of November 2, 2026, the company has 46 employees.
In which sector is NANOGROUP SPÓŁKA AKCYJNA located?▼
NANOGROUP SPÓŁKA AKCYJNA operates in the Health & Wellness sector.
When did NANOGROUP SPÓŁKA AKCYJNA complete a stock split?▼
NANOGROUP SPÓŁKA AKCYJNA has not had any recent stock splits.
Where is NANOGROUP SPÓŁKA AKCYJNA headquartered?▼
NANOGROUP SPÓŁKA AKCYJNA is headquartered in Warsaw, Poland.